Sanofi has confirmed intermittent supply issues affecting Lantus SoloStar insulin pens due to increased demand. Here's what ...
Nine percent of Americans, about 30 million people, have diabetes, according to the Centers for Disease Control and Prevention. About a fourth of them do not even know they have diabetes.
Ottawa, Feb. 02, 2026 (GLOBE NEWSWIRE) -- The global smart insulin pens market size is calculated at USD 1.02 billion in 2026 and is expected to reach around USD 2.42 billion by 2034, growing at a ...
Medtronic's launch of a new version of its smart insulin pen with integrated continuous glucose monitoring (CGM) is the first such "connected" device for use by people with diabetes who use multiple ...
Novo Nordisk has announced that two of its smart connected insulin pens, NovoPen 6 and NovoPen Echo Plus will be available within the NHS. NovoPen 6 and NovoPen Echo Plus are novel insulin pens that ...
(Reuters Health) - A warning for people who use insulin pens: Not shaking your NPH insulin pen before injecting can result in wide variations in your insulin level and blood sugar control, researchers ...
Sanofi is experiencing “a period of intermittent supply” of its Lantus SoloStar insulin pens in the U.S. amid rising demand, the drugmaker confirmed to Becker’s July 24. Lantus SoloStar is a prefilled ...
Doctors Without Borders (MSF) is calling on Eli Lilly, Novo Nordisk and Sanofi to immediately reduce the price of insulin pens to $1 per device in low- and middle-income countries (LMICs). Pens are ...
One batch of Semglee prefilled insulin injection pens has been recalled by Mylan Pharmaceuticals for missing labels. Batch No. BF20003118, expiration August 2022 of Semglee (insulin glargine injection ...
(RTTNews) - Mylan Pharmaceuticals Inc., affiliated to healthcare company Viatris Inc., is recalling certain Insulin Glargine (Insulin glargine-yfgn) Injection prefilled pens due to the potential for ...
Add Yahoo as a preferred source to see more of our stories on Google. Gov. Gavin Newsom speaks during a news conference announcing $11 insulin and prescription drugs with the CalRx program inside a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results